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Abstract
Background—Neonatal surgical injury triggers developmentally-regulated long-term changes
that include enhanced hyperalgesia and spinal microglial reactivity following reinjury. To further
evaluate priming of response by neonatal hindpaw incision, we investigated the functional role of
spinal microglial p38 mitogen-activated protein kinase following reincision in adult rodents.
Methods—Plantar hindpaw incision was performed in anesthetized adult rats, with or without
prior incision on postnatal day 3. Numbers and distribution of phosphorylated-p38 (1, 3, 24 h) and
phosphorylated extracellular signal-regulated kinase (15 min, 24 h) immunoreactive cells in the
lumbar dorsal horn were compared following adult or neonatal plus adult incision. Withdrawal
thresholds evaluated reversal of incision-induced hyperalgesia by p38 inhibition with intrathecal
SB203850.
Results—Neonatal injury significantly increased phosphorylated-p38 expression 3 h following
adult incision (55 ± 4 vs. 35 ± 4 cells per section, mean ± SEM, n = 6-7, P <0.01). Increased
expression was restricted to microglia, maintained across lumbar segments, and also apparent at 1
and 24 h. Preincision intrathecal SB203850 prevented the enhanced mechanical hyperalgesia in
adults with prior neonatal injury, and was effective at a lower dose (0.2 mg/kg vs. 1 mg/kg, n = 8,
P <0.05) and for a longer duration (10 vs. 3 days). Lumbar neuronal phosphorylated extracellular
signal-regulated kinase expression reflected the distribution of hindpaw primary afferents, but was
not significantly altered by prior incision.
Conclusions—Neonatal incision primes spinal neuroglial signalling, and reincision in adult rats
unmasks centrally-mediated increases in functional microglial reactivity and persistent
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hyperalgesia. Following early life injury, p38 inhibitors may have specific benefit as part of
multimodal analgesic regimes to reduce the risk of persistent postsurgical pain.
Introduction
Persistent post-surgical pain occurs in a significant proportion of adults and children.1,2
There is a need to identify predisposing factors and underlying mechanisms to more
specifically target high risk groups with the most effective preventive strategies.3-5 Severe
acute pain continues to be reported following adult and pediatric surgery6-8 and the intensity
of acute postoperative pain is a risk factor for the transition from acute to persistent post-
surgical pain in both adults4 and children.2 Neonates and infants requiring major surgery or
intensive care management are exposed to significant painful stimuli at a time when the
developing nervous system is vulnerable to changes in sensory experience.9,10 Prolonged
alterations in sensory function occur in children following neonatal intensive care, with
more marked change in those born preterm or who also require surgery.11-14 Sensitivity to
noxious stimuli is increased11,13 and prior neonatal surgery increases subsequent
perioperative pain and analgesic requirements.15 Therefore, neonatal pain and injury may
represent a specific risk factor for an increased degree or duration of pain following surgery
in later life.
Plantar hindpaw incision is an established model of postoperative pain, producing robust
hyperalgesia in adult, juvenile and neonatal rodents.16-18 Initial incision during the neonatal
period, but not at older ages, increases both the degree and duration of hyperalgesia
following subsequent incision.18,19 In adult rodents, hindpaw incision increases spinal
microglial reactivity, and inhibiting microglial function reduces hyperalgesia.19-22 However,
neonatal incision primes the spinal microglial response to subsequent injury, with microglial
reactivity (morphological changes identified with ionized calcium-binding adaptor
molecule-1, Iba1) both increased and accelerated following incision, and the
antihyperalgesic effects of the nonspecific microglial inhibitor minocycline are enhanced in
adult animals with prior neonatal incision.19
The mitogen-activated protein kinase (MAPK) p38 is involved in intracellular signalling in
spinal microglia. The phosphorylated form (p-p38) is linked to activation of transcription
factors that upregulate synthesis and release of proinflammatory mediators.23 Increased
expression of p-p38 is a key component of the microglial-neuronal signalling pathway, and
provides a functional marker of microglial reactivity that often precedes morphological
changes.24,25 In adult rodents microglial p-p38 MAPK expression peaks 24 h following
plantar incision and p38 inhibitors reduce mechanical hyperalgesia.20,21 We hypothesized
that priming of the spinal microglial response by neonatal incision would lead to increased
incision-induced p-p38 expression in adulthood. As functional changes were anticipated to
occur more rapidly in animals with prior neonatal incision, and to precede previously
identified morphological changes,19 our primary outcome was group differences in the
degree and distribution of p-p38 expression 3 h following adult incision. We also compared
dose-dependent antihyperalgesic effects of the p38 inhibitor SB203850. Finally, to
determine if spinal enhanced responses were driven solely by increased input from the
peripheral reinjured tissue, expression of phosphorylated extracellular signal-regulated
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kinase (pERK) was mapped throughout lumbar cord segments that receive afferent input
from the plantar hindpaw. These data further demonstrate long-term changes in spinal
microglial reactivity following neonatal surgical injury and identify microglial p38
inhibition as a specific target to minimise the enhanced hyperalgesia.
Materials and Methods
Animals
All experiments were performed under personal and project licences approved by the Home
Office, London, United Kingdom in accordance with the United Kingdom Animal
(Scientific Procedures) Act 1986. Reporting is based on The ARRIVE Guidelines for
Reporting Animal Research developed by the National Centre for the Replacement,
Refinement and Reduction of Animals in Research, London, United Kingdom.26 Male
Sprague-Dawley rat pups on postnatal day 3 (P3) or adults were obtained from the
Biological Services Unit, University College London. All animals were from the same
colony, bred and maintained in-house, and exposed to the same caging, diet and handling
throughout development. Litters were reduced to a maximum of 12 pups and weaned at P21,
with all animals maintained on a 12-h light/dark cycle at constant ambient temperature with
free access to food and water. Treatment groups were distributed across multiple litters
and/or adult cage groups (4-5 animals) to control for potential litter variability.
All procedures were performed during anesthesia with 2-4% isoflurane (Abbot, AbbVie
Ltd., Maidenhead, United Kingdom) in oxygen via a nose cone. The handling of rat pups
and duration of maternal separation were kept to the minimum possible, and pups were
maintained on a warming blanket before return to the dam. For behavioural studies, adult
animals were randomly selected from the home cage and numbered by the investigator (FS)
who measured baseline and all subsequent sensory thresholds. For each cage group, a
separate investigator (SW) created a random, nonsequential sheet for allocation of animals
to treatment groups, performed the injections, and retained the blinding sheet until
completion of the experiments. Animals tested at all time points and with no missing data
were included in the analyses. Tissue slides were also coded by an independent colleague to
ensure the experimenter was blinded to treatment group during cell counting.
Plantar incision
Following application of chlorhexidine gluconate 0.5% (Vetasept, Animalcare Ltd., York,
United Kingdom), a midline incision was performed on to the plantar aspect of the left
hindpaw, and the underlying plantaris muscle was elevated and incised longitudinally as
previously described.16 Incision extended from the distal midpoint of the heel to the level of
the first footpad to approximate the same relative length of incision in the hindpaw of pups
(postnatal day 3, P3) and young adults (6 weeks of age).18,19 Skin edges were closed with a
single loop suture in pups or two mattress sutures of 5-0 silk (Ethicon, Edinburgh, United
Kingdom) in adults which were removed after 5 days. Two experimental groups were
compared: (i) animals with neonatal incision at P3 and repeat incision 6 weeks later in early
adulthood (neonatal incision plus adult incision; nIN-IN); and (ii) age-matched adults
undergoing a single incision at 6 weeks of age (adult incision; IN).
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Intrathecal injection
Low lumbar spinous processes were visualised through a small midline skin incision, and a
30-gauge needle was passed in the midline through the lumbar (L) 4/5 or L5/6 intervertebral
space to perform intrathecal injection, as previously described.19 The p38 MAPK inhibitor
4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-5-(4-pyridyl)-1H-imidazole (SB203580)
(Sigma Aldrich, Gillingham, United Kingdom) was dissolved in a solution of 10% or 25%
dimethyl sulfoxide (DMSO; Sigma Aldrich) and saline to a final concentration of 1 mg/ml
or 5 mg/ml. The injectate volume (0.2 μl/g) was the same for all groups. Thirty min prior to
the adult plantar incision, animals received 0.2 mg/kg SB203580 in 10% DMSO or 1 mg/kg
in 25% DMSO, as a higher concentration of DMSO was required to form a solution of 5
mg/ml. Control animals in both IN and nIN-IN groups received equivalent volumes of
vehicle (10% DMSO, n = 5) or (25% DMSO, n = 4).
Behavioral Testing
Animals were habituated to the testing environment for 2 days before baseline testing. For
measurement of mechanical withdrawal threshold, animals were placed on an elevated mesh
platform and a mechanical stimulus (electronic von Frey device; Dynamic Plantar
Aesthesiometer, Ugo Basile, Varese, Italy) was applied to the hindpaw plantar surface
adjacent to, but not directly over, the incision to avoid disruption of the wound. A linear
increase in force was applied (ramp 2.5 g/s to a maximum of 50g) until a withdrawal reflex
was evoked. Mechanical threshold was defined as the mean of three responses. Thermal
withdrawal latency was determined using a modified Hargreaves Box (PAW thermal
stimulator, University Anaesthesia Research and Development Group, University of
California San Diego, La Jolla, California) with a glass surface (maintained at 30°C) on
which animals were placed in individual Plexiglas cubicles. The thermal nociceptive
stimulus from a focused projection bulb positioned below the glass surface was directed to
the midplantar hindpaw. Latency was defined as the time required for the paw to show a
brisk withdrawal as detected by photodiode motion sensors that stopped the timer and
terminated the stimulus. In the absence of a response within 20 s, the stimulus was
terminated. Thermal latency was defined as the mean of three responses.
Behavioral testing was performed at the following time points: baseline measures at 6 weeks
of age; following intrathecal injection to evaluate specific drug effects; and at regular
intervals following incision (4 h and 1, 2, 3, 7, 10, 14, 21 d).
Immunohistochemistry
For spinal cord immunohistochemistry, rats were terminally anesthetised with an
intraperitoneal injection of pentobarbitone 100 mg/kg (Euthetal®, Merial, Harlow, United
Kingdom) and transcardially perfused with heparinised saline followed by 4%
paraformaldehyde with 0.1M phosphate buffer. Tissue was obtained at different time points
following adult plantar incision for p-p38 and/or pERK immunohistochemistry. Lumbar
spinal cords were dissected and pinned transversely at L4 and longitudinally in the
contralateral ventral horn. Tissue was then postfixed overnight at 4°C. Following
cryoprotection in 30% sucrose, transverse sections were cut at 20 μm with a cryostat, and
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serial lumbar sections were mounted on Superfrost glass slides (Fisher, Superfrost Plus,
Fisher Scientific, Houston, TX) and stored at −20°C.
To assess changes in p-p38 immunohistochemistry at time points prior to our previously
demonstrated changes in Iba1 immunoreactivity in nIN-IN animals, spinal cords were
obtained 1, 3, and 24 h following incision. Sections were pretreated with 70% methanol and
30% hydrogen peroxide solution for 30 min at 4°C, blocked with 3% chicken serum in 0.3%
Triton X-100 for 1 h at room temperature, then incubated overnight with rabbit anti-p-p38
antibody (1:400; Cell Signaling, Danvers, CA). Sections were washed twice for 15 min in
0.1M phosphate buffer solution between steps. Sections were incubated with biotinylated
secondary antibodies (goat anti-rabbit; 1:400; Vector Stain) for 90 min, placed in ABC
complex (1:125; Vector Stain, ABC elite kit, Vector Labs, Burlingame, CA) for 30 min,
followed by biotinylated tyramide (1:75; Tyramide Signal Amplification, TSA Staining Kit;
Perkin Elmer, Waltham, MA) for 7 min, and then fluorescein isothiocyanate-Avidin (1:600;
Vector Stain, Vector Labs) for 2 h at room temperature. For double labelling, spinal sections
were incubated with monoclonal antibodies directed at mouse anti-neuronal specific nuclear
marker (NeuN, 1:500; Millipore, Hertfordshire, United Kingdom), mouse glial fibrillary
acid protein to identify astrocytes (1:200, Cell Signaling) or goat ionized calcium-binding
adapter molecule 1 (Iba-1) as a microglial marker (1:100 Abcam, Cambridge, United
Kingdom) overnight at room temperature then visualised using anti-mouse/goat Alexa 594
(1:200; Invitrogen, Paisley, United Kingdom) for 2 h at room temperature.
For pERK staining, tissue was obtained 15 min from the commencement of plantar incision
to ensure tissue collection was standardized from the onset of injury, and not influenced by
the time to perform the incision and/or suturing. Additional comparisons were made 24 h
following incision. Spinal cord sections were blocked with 3% goat serum in 0.3% Triton
X-100 for 1 h, then incubated overnight at room temperature with rabbit anti-p44/42
(pERK1/2) antibody (1:200; Cell Signaling) and mouse anti-NeuN antibodies (1:500;
Millipore). Additional double labelling was performed with goat ionized calcium-binding
adapter molecule 1 (Iba-1) as a microglial marker (1:100 Abcam). Slides were then
incubated for 2 h with anti-rabbit Alexa 488 (1:200; Invitrogen, Eugene, OR) and anti-
mouse or anti-goat Alexa 594 (1:200; Invitrogen, Paisley, United Kingdom). In all
protocols, sections were coverslipped with Flouromount (Sigma Aldrich). Negative controls
omitting primary antibodies resulted in no immunofluorescence.
Spinal cord sections were visualised at a magnification of x60 on a Leica microscope using
the appropriate fluorescent filter. For quantification of p-p38 in the L4-5 spinal cord dorsal
horns (laminae I-V) cell counts from 10 randomly chosen sections were averaged, and n
represents the number of animals. For cephalad-caudal signal tracing, cell counts of p-p38 in
serial L4/5 dorsal horn sections were plotted. For pERK, cells in the ipsilateral superficial
dorsal horn were counted in serial sections from L2 to L6 as previously described.27 Images
were obtained using an Olympus total internal reflection fluorescence confocal microscope
(Olympus, Southend-on-Sea, United Kingdom) with 20x and 40x objectives applied at a z-
spacing of 0.6 μm and 0.5 μm respectively.
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Statistical Analysis
Our primary outcome was the difference in p-p38 positive cell counts between IN and nIN-
IN groups 3 h following adult incision. The number of animals per group was based on
previous work following plantar incision in adult rats that used similar methodology and
identified significant increases (P <0.01 and P <0.001) in p-p38 counts in the dorsal horn
with n = 5-7 animals,20 and our findings of group differences (IN vs. nIN-IN, P <0.01) in the
degree, distribution and time course of Iba1 immunohistochemistry with n = 4-6 animals.19
Phospho-p38 cell counts were obtained from 10 randomly selected L4/5 sections and an
average obtained for each animal. Counts in naïve, nIN-IN and IN groups at 1, 3, and 24 h
following incision were compared with one-way ANOVA (n = number of animals). In
additional control experiments, cell counts were compared in nIN-IN animals 3 h following
SB203580 0.2 mg/kg and 1 mg/kg. To quantify and compare the degree and distribution of
p38 and pERK staining the area under the curve of cell count in serial sections versus spinal
cord length was calculated for each animal, and results combined.
Sample sizes for behavioural testing were based on our previously reported group
differences between IN and nIN-IN animals with n = 8 (P <0.01-0.001).19 Values for
baseline mechanical withdrawal threshold and thermal withdrawal latency in nIN-IN and IN
groups were normally distributed (D’Agostino and Pearson omnibus normality test). In
vehicle-treated groups, sensory thresholds were also plotted as the percentage change from
baseline by calculating [(baseline preincision threshold − postincision threshold) / baseline
threshold] × 100 for each animal at each time point. The degree and the duration of
hyperalgesia in both the nIN-IN and IN groups were assessed by within-group comparisons
between ipsilateral incised and contralateral paw using two-way repeated measures ANOVA
followed by Bonferroni post-hoc comparisons. Using within group raw data, mechanical
withdrawal thresholds following vehicle, 0.2 mg or 1.0 mg SB203580 were analysed by
two-way repeated measures ANOVA (time and drug dose as variables) followed by
Bonferroni multiple post-hoc comparisons. Within experiment outcomes were not corrected
for the number of comparisons.
To compare the overall behavioral response in the two weeks following incision, changes in
sensory threshold were plotted against time and the hyperalgesic index for each animal was
calculated as the area over the curve from baseline (0) to 14 days,28 such that a larger area
over the curve represents a greater change from baseline and greater degree and/or duration
of hyperalgesia19 and comparisons were made with unpaired two-tailed Student’s t-test.
Data were analysed using Prism Version 6.0 (GraphPad, San Diego, CA), and P <0.05 was
considered statistically significant.
Results
Incision-induced phospho-p38 expression in spinal microglia is primed by prior neonatal
incision
As we have previously shown that microglial morphological changes following adult
incision occur earlier (24 h vs. 3 days) in animals with prior neonatal incision,19 and p-p38
expression in spinal microglia peaks 24 h following single adult incision,20 we used p-p38
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expression to compare functional microglial reactivity up to this time point (1, 3, and 24 h,
fig. 1). Representative spinal cord sections show p-p38 immunoreactive cells in the medial
dorsal horn from an IN (fig. 1Ai) and nIN-IN (fig. 1Aii) animal. Three hours following adult
incision p-p38 immunoreactive cell counts were increased in both IN (n = 8) and nIN-IN (n
= 7) groups, but to a greater degree in animals with prior neonatal incision (P <0.01, one
way ANOVA followed by Bonferroni post-hoc comparisons; fig. 1B). To compare both the
degree and distribution of p-p38 expression, cell counts in serial sections of L4/5 cord 3 h
following incision were plotted from cephalad to caudal (fig. 1C). Cell counts were
consistently higher in the nIN-IN group, and significant group differences were found when
the area under the cell count versus spinal length curve was calculated for each animal (P
<0.05 unpaired two-tailed Students t-test; fig. 1D). Double labelling with the microglial
marker Iba-1 confirmed expression of p-p38 in microglia 3 h following incision, but there
was no overlap with astrocyte (glial fibrillary acid protein) or neuronal (NeuN) markers (fig.
2).
To further evaluate the time course of microglial reactivity, p-p38 cell counts were also
compared at 1 and 24 h. One hour following incision, p-p38 expression in the nIN-IN (n = 5)
group was significantly higher than in nonincised controls (n = 4) (nIN vs. naive, P <0.001,
one way ANOVA followed by Bonferroni post-hoc comparisons), whereas values in the IN
group (n = 5) were lower (IN vs. nIN-IN, P <0.05) and did not differ significantly from the
naïve group (fig. 1A). At 24 h, increased pp38 expression persisted in both IN ( n =7) and
nIN-IN (n = 5) groups. Overall, p-p38 expression was enhanced by prior neonatal incision,
with a main effect of incision group (F1,31 = 28.9, P <0.001) as well as time (F2,31 = 6.71, P
= 0.0038) (two-way ANOVA with time and incision group as variables followed by
Bonferroni post-hoc comparisons).
Antihyperalgesic efficacy of p38 inhibition is enhanced following initial neonatal incision
SB203850 was prepared in a solution of 10% DMSO (0.2 mg/kg) or 25% DMSO (1 mg/kg).
Mechanical withdrawal thresholds measured 15 min following intrathecal injection (but
prior to incision) confirmed that drug and/or vehicle alone did not alter reflex thresholds
(table 1). Within either the IN or nIN-IN groups, sensory thresholds did not differ at any
time point between vehicle control animals receiving 10% DMSO (n = 5) or 25% DMSO (n
= 4)(IN P = 0.94; nIN-IN P = 0.14; repeated measures two-way ANOVA with time and
DMSO concentration as variables followed by Bonferroni post-hoc comparison). Therefore,
data are combined as a single vehicle control group in subsequent analyses.
Baseline sensory thresholds of both the previously injured hindpaw and the contralateral
uninjured paw were increased compared to age-matched adult control animals (table 1) as
previously reported following neonatal incision19 and neonatal hindpaw inflammation.29
Mechanical withdrawal threshold and thermal latency from vehicle controls are expressed as
percentage change from baseline for each animal to compare IN (n = 9) and nIN-IN (n = 9)
groups in figure 3, with the raw data also shown in figure 4. The enhanced hyperalgesia in
animals with prior neonatal incision replicates our previous findings,19 and group
differences are not altered by intrathecal DMSO. The increased degree (nIN-IN > IN from 4
h to 10 days postincision, P <0.05 to P <0.001, two-way repeated measures ANOVA with
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time and incision group as variables followed by Bonferroni post-hoc comparisons; fig. 3A),
and duration of mechanical hyperalgesia (ipsilateral vs. contralateral paw; two-way repeated
measures with time and paw as variables; P <0.001 all time points to 10 days in nIN-IN
group; P <0.05 to 3 days in IN group) was also reflected by a significant increase in the
mechanical hyperalgesic index (nIN-IN > IN, P <0.01 Student’s t-test; fig 3B). Similarly,
the degree of change in thermal latency following adult incision was greater (nIN-IN > IN
from 4 h to 10 days, P <0.05 to P <0.001, two-way repeated measures ANOVA with time
and incision group as variables followed by Bonferroni post-hoc comparisons; fig. 3C), and
the duration was longer in animals with prior neonatal incision (ipsilateral vs. contralateral
paw; P <0.001 all time points to 10 days in nIN-IN; P <0.01 to 3 days in IN group; two-way
repeated measures with time and paw as variables), and a significant increase in the thermal
hyperalgesic index (nIN-IN > IN, P <0.01 Student’s t-test; fig. 3D).
To determine if increased p-p38 expression in the spinal cord was linked to the enhanced
behavioural response, dose-dependent effects of an intrathecal p38 inhibitor were compared.
Intrathecal SB203580 reduced adult incision-induced mechanical hyperalgesia in both IN
and nIN-IN groups, but dose requirements differed (fig. 4). A single pre-incision dose of
1mg/kg SB203580 (n = 6) reduced mechanical hyperalgesia for 3 days following adult
incision when compared to both vehicle (n = 9) and 0.2 mg/kg (n = 8) groups (P <0.01, two-
way repeated measures ANOVA followed by Bonferroni post-hoc comparisons; fig. 4A).
The mechanical hyperalgesic index (0-14 days) was also reduced by 1 mg/kg but not 0.2
mg/kg SB203580 (P <0.001 one way ANOVA followed by Bonferroni post-hoc
comparisons; fig. 4B). By contrast, in nIN-IN animals a lower dose of 0.2 mg/kg SB203580
(n = 8) significantly reduced mechanical hyperalgesia for a longer time period (P <0.01 to 7
days, two-way repeated measures ANOVA followed by Bonferroni post-hoc comparisons;
fig. 4C). Intrathecal SB203580 1 mg/kg (n = 8) produced anti-hyperalgesic effects for 10
days following incision, and produced a greater dose-dependent reduction in the mechanical
hyperalgesic index (fig. 4D). Plotting the degree of reversal of hyperalgesia (with vehicle
treated animals normalized to zero) allowed comparison of dose-dependent effects, and
demonstrated increased efficacy in the nIN-IN versus IN group (fig. 4F). Control
experiments in nIN-IN animals confirmed that intrathecal SB203580 0.2 mg/kg (n = 3) and
1 mg/kg (n = 4) reduced p-p38 expression (P <0.05 one way ANOVA; fig. 4E).
As previously reported after adult plantar incision,20 p38 inhibition had no effect on thermal
hyperalgesia (fig. 4G and H). Consistent with the group differences expressed as percentage
change in figure 3C, analysis of the thermal latency raw data demonstrates significant
reductions at all time points to 3 days in the IN vehicle control group (n = 9; P <0.01-0.001,
two-way repeated ANOVA with time and treatment as variables followed by Bonferroni
post-hoc comparisons; fig. 4G) and to 10 days following nIN-IN (n = 9, P <0.01-0.001; fig.
4H). Thermal latency was not altered by SB203580 with no main effect of treatment in
either the IN (F2,20 = 0.173, P = 0.17) or nIN-IN (F2,22 = 0.68, P = 0.52; two-way repeated
ANOVA with time and treatment as variables followed by Bonferroni post-hoc
comparisons) groups.
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Incision-induced pERK expression is similar in animals with and without prior neonatal
injury
To test whether prior neonatal injury alters the pattern of neuronal activation in the spinal
dorsal horn, pERK expression was quantified and compared in IN and nIN-IN groups 15
min following the commencement of adult incision (n = 10 both groups) and also at 24 h (n
= 4 both groups, fig. 5). A representative lumbar section 15 min following commencement
of plantar incision demonstrates pERK immunoreactivity in the ipsilateral superficial dorsal
horn (fig. 5Ai) with higher power images showing colocalization with the neuronal marker
NeuN (fig. 5Aii-iv). At both 15 min (fig. 5Bi, ii) and 24 h (fig. 5Biii,iv), pERK staining
colocalized with NeuN but not with the microglial marker Iba1 (fig. 5Bii, iv). Counts of
pERK from L4/5 segments (10 sections per animal) were significantly higher at 15 min
versus 24 h (P <0.001) but did not differ between IN and nIN-IN groups at either time point
(two way ANOVA followed by Bonferroni post-hoc comparisons; fig. 5C). The segmental
expression of pERK in serial lumbar cord sections (L2 to L5) followed a similar pattern in
both groups (fig. 5D) and correlated with the primary afferent terminal fields of the plantar
nerves innervating the hindpaw (fig. 5E). Quantification of the area under the cell count
versus cord length graph found no significant differences between the IN and nIN-IN
animals in L2/3 or L4/5 (fig. 5F).
Discussion
Neonatal hindpaw incision produces long-term alterations in injury response, with enhanced
neuroglial signalling in the spinal cord and an increased degree and duration of hyperalgesia
following adult incision. In animals with prior neonatal incision, functional microglial
reactivity was enhanced as indicated by a greater degree and more rapid onset of p-p38
expression in dorsal horn microglia, and associated hyperalgesia was more effectively
targeted by the p38 inhibitor SB203580. Whereas increased microglial p-p38 expression in
the prior neonatal incision group was evident throughout lumbar segments, the pattern of
neuronal pERK expression following adult incision was not significantly different. These
findings support and extend our previous work identifying microglial priming by neonatal
injury as key to centrally-mediated enhanced injury responses in later life. In addition, p38
inhibitors may have a specific preventive role as part of multimodal analgesic regimes for
those with an increased risk of persistent postsurgical pain following early life injury.
Neuroglial interactions in the spinal cord modulate pain sensitivity, sustain central
sensitization, and contribute to the transition from acute to persistent pain.30-33 Microglia
have significant functional plasticity, and can be primed by prior experience.34 Adult
animals with prior neonatal incision were indistinguishable from age-matched naïves in
terms of baseline microglial Iba1 immunoreactivity.19 However, repeat incision unmasked
an increased degree, distribution and duration of microglial reactivity. Morphological
changes are indicative of reactive phenotypes but may not always predict function,30,35 and
so here we evaluated activation of the intracellular signalling MAPK p38. Phosphorylation
of p38 leads to upregulated release of pro-inflammatory mediators from microglia, and
amplification of pronociceptive signals in the dorsal horn.36,37 Skin and muscle incision in
adult rodents increases p-p38 cell counts in the spinal cord from 1 h to 3 days,20,21,38 and p-
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p38 protein at 1-5 days.39 Although neuronal p-p38 expression has been identified at much
later time points in some injury models,21 p-p38 is expressed exclusively in microglia during
the first 1-3 days following plantar incision20,40 or nerve injury.23 Here we show that prior
neonatal incision significantly enhanced the response following adult incision, with a more
rapid onset and greater degree of microglial p-p38 expression that extended throughout the
L4/5 cord. These data support our hypothesis that neonatal injury primes spinal microglia
and that reinjury in later life unmasks enhanced microglial reactivity, in turn driving an
increased degree and duration of hyperalgesia.
The enhanced spinal response could simply be a consequence of increased primary afferent
input from the reinjured tissue. We previously demonstrated that the same standardized
primary afferent input (electrical stimulation of the tibial nerve) produced a greater degree of
hyperalgesia and microglial reactivity in adult animals with prior neonatal incision,
suggesting that the long-term changes are spinally-mediated and not solely driven by
peripheral reinjury.19 As peripheral noxious stimuli induce ERK phosphorylation in spinal
dorsal horn neurons in an intensity-dependent and somatotopically-appropriate manner,25
we now mapped incision-induced pERK expression to identify potential alterations in
primary afferent input from the reinjured tissue. Following adult plantar incision increased
neuronal pERK expression in the ipsilateral L4-5 spinal cord has been reported at 30 min41
or at 1 to 5 min “after the establishment of incisional pain”42 (rather than timing from the
beginning of incision as here), with more prolonged increases in pERK protein (maximal at
4 h).43 Neuronal pERK expression was increased throughout the lumbar cord in a
distribution consistent with the primary afferent terminal field of the medial and lateral
plantar nerves from the hindpaw.44 By 24 h, pERK expression had decreased in both groups
but remained restricted to neurons, whereas de novo microglial expression has been reported
at later time points following spinal nerve ligation.45,46 The lack of significant differences in
the degree or distribution of neuronal pERK expression suggest similar primary afferent
input in both groups, supporting our hypothesis that centrally-mediated mechanisms are
important mediators of long-term changes in pain response. As neonatal incision also
produces developmentally regulated and long-term increases in excitatory47,48 and
reductions in inhibitory49 synaptic signalling in the dorsal horn, changes in neuronal and/or
microglial reactivity may contribute to the enhanced central hyperalgesic response.
Strategies to minimise the long-term impact of neonatal surgery may be directed at
improving analgesia at the time of initial injury and/or more specifically targeting
mechanisms underlying enhanced hyperalgesia following subsequent surgery.
Neuroimmune interactions represent a major potential therapeutic target for management of
persistent pain.30,50 However as microglia have multifaceted responses with a spectrum of
activity from proinflammatory through to antiinflammatory roles in tissue repair, capturing
beneficial effects alone is problematic.51 Microglia also have specific roles during postnatal
development and inhibiting synaptic pruning and remodelling or the phagocytosis of
apoptotic debris associated with programmed cell death may produce adverse effects on
neural circuitry.50-52 As local anaesthetic blockade with slow-release bupivacaine prevented
nerve-injury induced increases in p-p3853,54, blocking primary afferent input may prevent
priming, while avoiding more direct microglial inhibition. We have previously shown that
perioperative sciatic nerve blockade at the time of neonatal incision prevented the enhanced
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hyperalgesic response to future surgery.18 In addition, we have recently evaluated the ability
of sciatic blockade to prevent changes in descending modulation following neonatal incision
(Walker et al. Surgical injury in the neonatal rat alters the adult pattern of descending
modulation for the rostroventral medulla. Anesthesiology 2015;122:xx-xx). Descending
pathways that modulate spinal reflex sensitivity undergo significant postnatal
maturation,10,55-57 and injury-induced changes may underlie the delayed emergence and
generalized distribution of elevated sensory thresholds following neonatal hindpaw
inflammation29 or incision.19 Enhanced inhibitory modulation from the rostroventral
medulla has been demonstrated following neonatal inflammation,58 and we are currently
assessing the pattern of inhibition or facilitation of spinal reflex sensitivity by rostroventral
medulla stimulation55 in adults with prior neonatal incision.
Reducing microglial reactivity at the time of adult incision may minimise the impact of prior
neonatal injury. We previously demonstrated selective antihyperalgesic effects with low
dose intrathecal minocycline in adult rats undergoing repeat incision.19 Although intrathecal
minocycline inhibits both morphological changes and reduces p-p38,28 there are additional
nonspecific effects on spinal synaptic signalling59 and peripheral antiinflammatory effects
following systemic administration.19,60 Inhibition of p38 represents a more specific
target.25,61 Pretreatment with intrathecal SB203580 reduced hyperalgesia following anterior
thigh skin/muscle incision and retraction21 and spinal nerve ligation,62 and in some studies
was more effective in the induction than maintenance phase.23 When administered 24 or 72
h following adult plantar incision intrathecal SB203850 had no effect on mechanical
thresholds,40 but here administration prior to incision had dose-dependent antihyperalgesic
effects that outlasted the duration of action of the drug (i.e., preventive analgesic effects).63
Inhibition of p38 specifically targeted the enhanced mechanical hyperalgesia in animals with
prior neonatal injury, as dose requirements were lower and effects prolonged. However,
MAPK inhibitors directed at p3820 or ERK43 do not alter thermal hyperalgesia following
hindpaw incision. Modality-specific mechanisms have not been elucidated but the focus on
mechanical hyerpalgesia39 may be clinically appropriate as movement-evoked pain
significantly effects post-operative mobilization and morbidity.20,43,64
Clinical implications
Repeat incision represents a clinically relevant model as multiple surgeries are not
uncommon during childhood,65,66 particularly in those with complications of preterm birth
or complex congenital anomalies. Neonatal surgery has been associated with increased pain
and perioperative analgesic requirements following subsequent surgery in infancy.15 As
microglial precursors colonize the human central nervous system during early development,
with a major influx in human fetal spinal cord between 14 and 16 postgestational weeks,67
the developmental trajectory and phenotypic diversity of microglia are suited to roles in
long-term changes in spinal connectivity and sensitivity. In addition to biological factors
associated with increased central sensitization and persistent pain, early life experience
influences psychological factors, such as pain catastrophizing and parental responses,13
associated with persistent postsurgical pain in children2,68 and adults.4 This further
emphasizes the need for improved understanding and management of neonatal pain to
minimize long-term consequences.
Schwaller et al. Page 11
Anesthesiology. Author manuscript.
 Europe PM
C
 Funders A
uthor M
anuscripts
 Europe PM
C
 Funders A
uthor M
anuscripts
Inhibition of p38 represents a potential analgesic target for persistent pain,61 and p38
inhibitors are currently in clinical trials.61,69-71 Efficacy will depend on formulations with
adequate potency and selectivity72 being administered to an appropriate patient group at the
right time. In adults with established neuropathic pain70,71 or active rheumatoid arthritis73
p38 inhibitors have shown small or no analgesic benefit. Although laboratory studies
suggest reduced efficacy during the maintenance phase of incisional pain,21,40 our data
indicate benefit with preincision administration of p38 inhibitors. Preinjury dosing is
specifically applicable to clinical anesthetic practice and an oral p38 inhibitor (SCIO-469)
prior to adult dental extractions reduced pain to a similar degree as ibuprofen and prolonged
time to first analgesia compared to placebo.69 The partial reversal of mechanical
hyperalgesia by p38 inhibitors shown here suggests use in multimodal therapy to reduce
movement-evoked pain. Benefits of perioperative multimodal analgesic therapy are well-
established in both adult and pediatric practice.74-76 The lower dose requirements and
preventive analgesic effects of p38 inhibition following repeat surgery suggest a specific
benefit in patients with prior surgery in early life. Current evidence for pharmacological
prevention of persistent postsurgical pain is limited77 and studies including children are
required.78 Identifying specific mechanisms underlying persistent pain will ensure the most
appropriate treatments are evaluated in at-risk groups, to ultimately inform improvements in
perioperative management and reduce both the degree and duration of postoperative pain.
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Final Boxed Summary Statement
What we already know about this topic:
* In rodents, neonatal surgery augments pain behaviors after surgery in adults,
although the mechanisms are unclear
What this article tells us that is new:
* In rats, incisional surgery in adulthood resulted in greater phosphorylation of the
signaling enzyme, p38 MAP kinase in spinal cord microglia of animals which had
received incisional surgery in the neonatal period
* A p38 MAP kinase inhibitor reduced pain behaviors after surgery in adults with
prior neonatal surgery, suggesting this enzyme may be a target to reduce exaggerated
pain responses after surgery in individuals with a history of neonatal surgery
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Figure 1.
Expression of phosphorylated p38 (p-p38) in the ipsilateral lumbar dorsal horn following
plantar incision. (A) Examples of p-p38 immunoreactivity in the ipsilateral superficial dorsal
horn with the inset at higher magnification are shown 3 h following adult incision in an IN
(Ai) and nIN-IN (Aii) animal. Scale bar = 200 μm. (B) Counts of p-p38 immunoreactive
positive cells (p-p38-ir; average from 10 lumbar sections per animal) in the superficial
dorsal horn are shown for naïve animals and at time points (1, 3, and 24 h) following adult
incision (IN) and in animals with prior neonatal and adult incision (nIN-IN). Counts were
significantly increased compared with naïve (n = 4) at 1 h (n = 5), 3 h (n = 7), and 24 h (n =
8) in the nIN-IN group, but at 3 h (n = 8) and 24 h (n = 5) in the IN group. Bars = mean ±
SEM, ** P <0.01, *** P <0.001, one-way ANOVA followed by Bonferroni post-hoc
comparisons. Counts were significantly higher in the nIN-IN vs. IN group at 1 (§ P <0.05)
and 3 h (§§ P <0.01). (C) Graphical display of cell counts vs. spinal length from serial
sections of the 4th and 5th lumbar cord segments (L4-L5) 3 h following incision. The
average cell count per 5 serial sections was calculated for each animal. Group values are
plotted from cephalad to caudal. (D) The area under the p-p38-ir cell count (area under the
curve [AUC] L4-5) vs. spinal length was calculated for each animal. Data points = mean ±
SEM; nIN-IN (n = 7) > IN (n = 8), * P <0.05 unpaired two-tailed Student’s t-test.
Schwaller et al. Page 18
Anesthesiology. Author manuscript.
 Europe PM
C
 Funders A
uthor M
anuscripts
 Europe PM
C
 Funders A
uthor M
anuscripts
Figure 2.
Phospho-p38 is expressed by microglia in the spinal cord following plantar incision. High
power images from the ipsilateral spinal dorsal horn 3 h following adult incision (IN) (A i-
iii) and neonatal plus adult incision (nIN-IN) (B iv-vii). Double- labelling demonstrates co-
localisation of p-p38 with the microglial marker ionized calcium-binding adaptor molecule
(Iba1) (i, iv), confirmed in xz, xy and yz planes (vii). Phospho-p38 is not coexpressed with
glial (glial fibrillary acid protein [GFAP]) or neuronal (NeuN) markers at this time point.
Scale bar = 50 μm.
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Figure 3.
Prior neonatal incision increases the degree and duration of incision-related mechanical and
thermal hyperalgesia in adulthood. (A) Mechanical withdrawal threshold of the incised (ipsi)
and contralateral (contra) paws of vehicle control animals are expressed as percentage
change from baseline ([(baseline preincision threshold − postincision threshold) / baseline
threshold] × 100) and plotted against time for 3 weeks following incision in previously naïve
adults (IN) and adults with prior hindpaw incision (nIN-IN). The degree of change in
threshold in the incised paws was significantly greater in the nIN-IN group from 4 h to 10
days postincision. Measures in contralateral paws did not differ from baseline at any time
point. Data points = mean ± SEM, n = 9 per group, IN ipsi vs. nIN-IN ipsi * P <0.05, ** P
<0.01, *** P <0.001 two way repeated measures ANOVA followed by Bonferroni post-hoc
comparisons. (B) The mechanical hyperalgesic index (area over the mechanical threshold
curve for each animal from baseline to 14 days) was significantly greater in the nIN-IN
group. Bars = mean ± SEM, n = 9 per group, *** P <0.001 unpaired two tailed Students t-
test.
(C) Changes in thermal withdrawal latency of the incised and contralateral paws are plotted
against time. Significant differences between nIN-IN and IN ipsilateral paws were seen from
4 h to 7 days post incision. Data points = mean ± SEM, n = 9 per group, * P <0.05, ** P
<0.01, *** P <0.001 two-way repeated measures ANOVA followed by Bonferroni post-hoc
comparisons. (D) The thermal hyperalgesic index was also significantly greater in the nIN-
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IN group. Bars = mean ± SEM, n = 9 per group, *** P <0.001 unpaired two tailed Students
t-test.
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Figure 4.
Preincision administration of the p38 inhibitor SB203580 dose-dependently reduces
mechanical hyperalgesia. (A) Mechanical withdrawal threshold is plotted against time
following adult incision (IN). Preincision administration of 1 mg/kg SB203580 (n = 6)
significantly reduces mechanical hyperalgesia for 3 days when compared to both vehicle
control (n = 9) and 0.2 mg/kg SB203580 (n = 8) groups. Data points = mean ± SEM; ** P
<0.01, *** P <0.001; two-way repeated measures ANOVA with time and treatment as
variables followed by Bonferroni post-hoc comparisons. (B) The mechanical hyperalgesic
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index (area over the threshold versus time graph from 0-14 days) also demonstrated a
significant reduction following 1 mg/kg SB203580, but no effect with 0.2 mg/kg in the adult
incision (IN) group. Bars = mean ± SEM; *** P <0.001 one-way ANOVA followed by
Bonferroni post-hoc comparisons.
(C) Incision-related mechanical hyperalgesia in animals with prior neonatal incision (nIN-
IN) is reduced by 0.2 mg/kg or 1 mg/kg SB203580 (n = 8 both groups). Data points = mean
± SEM; vehicle (n = 9) vs. 0.2 mg/kg § P <0.05, §§ P <0.01 §§§ P <0.001; vehicle vs. 1
mg/kg * P <0.05 ** P <0.01 *** P <0.001; two-way repeated measures ANOVA with time
and treatment as variables followed by Bonferroni post-hoc comparisons. (D) The
mechanical hyperalgesic index is significantly reduced following both 0.2 mg/kg and 1
mg/kg SB203580 in nIN-IN animals. Bars = mean ± SEM; * P <0.05 *** P <0.001; one-
way ANOVA followed by Bonferroni post-hoc comparisons. (E) Representative spinal
dorsal horn sections from nIN-IN animals following vehicle (i) or 0.2 mg/kg SB203580 (ii).
Cell counts (average of 10 L4/5 sections per animal, n = 3-5 animals per group) confirm
reduction in p-p38 cell counts following SB203580 (iii). Bars = mean ± SEM; * P <0.05 one
way ANOVA. (F) To compare efficacy between IN and nIN-IN groups, the hyperalgesic
index in the vehicle group was normalized to zero and the percentage reversal shown for
each drug dose. Efficacy is demonstrated following 0.2 mg/kg only in the nIN-IN group.
Data points = mean ± SEM; nIN-IN vehicle vs. drug, ** P <0.01 0.2 mg/kg vs. vehicle in
nIN-IN group §§§ P <0.001 1 mg/kg vs. vehicle in IN and nIN-IN group; two-way ANOVA
with incision group and drug dose as variables followed by Bonferroni post-hoc
comparisons. (G) Thermal withdrawal latency is significantly reduced from baseline for 3
days following adult incision (IN) in vehicle (n = 9) 0.2 mg/kg SB203580 (n = 8) and 1
mg/kg SB203580 (n = 6) groups. Data points = mean ± SEM, *** P <0.001 one-way
repeated measures ANOVA followed by Bonferroni post-hoc comparisons. Values are not
altered by SB203850 at any time point (two-way ANOVA with time and treatment as
variables followed by Bonferroni post-hoc comparisons). (H) Thermal withdrawal latency is
significantly reduced from baseline for 10 days following neonatal plus adult incision (nIN-
IN) in vehicle (n = 9) 0.2 mg/kg SB203580 (n = 8) and 1 mg/kg SB203580 (n = 8) groups.
Data points = mean ± SEM, ** P <0.01, *** P <0.001 one-way repeated measures ANOVA
followed by Bonferroni post-hoc comparisons. Values are not altered by SB203850 at any
time point (two-way ANOVA with time and treatment as variables followed by Bonferroni
post-hoc comparisons).
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Figure 5.
Degree and distribution of phosphorylated extracellular signal-regulated kinase (pERK)
expression in the lumbar spinal cord following plantar incision. (A) Representative pERK
staining with double labelling of ipsilateral dorsal horn (i, scale bar = 100 μm) and high
power view (ii) confirming expression of p-ERK (green, iii) in neurons (NeuN, red, iv) 15
min following commencement of plantar incision. (B) Double-labelling of sections at 15 min
(i, ii) or 24 h (iii, iv) demonstrated coexpression of pERK with NeuN but not the microglial
marker Iba1 at both time points (scale bar = 50 μm). (C) Counts of pERK-immunoreactive
positive cells (pERK-ir) in adult-only (IN) and prior neonatal plus adult incision (nIN-IN)
groups are shown 15 min following the commencement of incision (n = 10 per group) and at
24 h (n = 4 per group). For each animal, the cell count was averaged from 10 randomly
selected lumbar cord (L4/5) sections. Cell counts were significantly higher at 15 min vs. 24
h (P < 0.001) but did not differ between IN and nIN-IN groups at either time point (two way
ANOVA followed by Bonferroni post-hoc comparisons). (D) The degree and distribution of
pERK-IR cells 15 min following incision was quantified from serial lumbar sections and
mapped against spinal length. The average cell count per five serial sections from L2-5 cord
was calculated for each animal. Group values are plotted from cephalad to caudal and
showed a similar pattern in both IN and nIN-IN groups. Data points = mean ± SEM, n = 10
animals per group. (E) The distribution of pERK staining correlates with the segmental
distribution of afferent fibres from the medial and lateral plantar nerves (redrawn from
Molander C, Grant G: Laminar distribution and somatotopic organization of primary
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afferent fibers from hindlimb nerves in the dorsal horn. A study by transganglionic transport
of horseradish peroxidase in the rat. Neuroscience 1986; 19: 297-312; reproduced with
permission from Elsevier. Adaptations are themselves works protected by copyright. So in
order to publish this adaptation, authorization must be obtained both from the owner of the
copyright in the original work and from the owner of copyright in the translation or
adaptation). (F) The area under the curve (AUC) for cell counts vs. spinal length was
calculated for L2/L3 and L4/L5, and did not differ between treatment groups (nIN-IN vs. IN
P >0.05, one-way ANOVA). Bars = mean ± SEM, n = 10 per group.
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